Healthy volunteers help unlock best way to take new cancer pill
NCT ID NCT07550946
First seen May 07, 2026 · Last updated May 25, 2026 · Updated 5 times
Summary
This early-stage study enrolls 24 healthy adults to see if food or a common stomach-acid drug (PPI) changes how the body absorbs a new experimental drug, VRN101099, being developed for solid tumors. Participants will take the drug under different conditions—with or without food and with or without a PPI—and researchers will measure drug levels in blood and urine. The goal is to find the best dosing instructions for future cancer patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nucleus Network
Melbourne, Victoria, 3004, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.